In this episode, Senior Editor Ivana Nedic is joined by Prof Jeffrey V Lazarus and Prof John Dillon, leading experts in liver health, to discuss the urgent need to improve diagnosis and care for metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, MASH.

Building on insights from the recent Global Steatotic Liver Disease Think-Tank and a new health policy paper in The Lancet Regional Health – Europe, the conversation explores the disease's rising burden, diagnostic challenges, emerging therapies, and how health systems must adapt. With a focus on the social determinants of health, stigma and innovation, this episode offers a timely look at one of Europe’s fastest-growing and still under-recognised public health threats.

Read the full article:

https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(25)00112-7/fulltext?dgcid=buzzsprout_icw_podcast_July_25_lanepe